ACCELERON PHARMA INC. Operating Income
ACCELERON PHARMA INC. reported Operating Income of -$70.63 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-11-04
- ACCELERON PHARMA INC. operating income (loss) for the quarter ending 2021-09-30 was -$70.63M.
- ACCELERON PHARMA INC. operating income (loss) for the quarter ending 2021-06-30 was -$63.66M.
- ACCELERON PHARMA INC. operating income (loss) for the quarter ending 2021-03-31 was -$63.60M.
- ACCELERON PHARMA INC. operating income (loss) for the quarter ending 2020-12-31 was -$57.59M.
- ACCELERON PHARMA INC. operating income (loss) for fiscal 2020 was -$167.31M.
- ACCELERON PHARMA INC. operating income (loss) for fiscal 2019 was -$136.44M.
- ACCELERON PHARMA INC. operating income (loss) for fiscal 2018 was -$124.41M.
- ACCELERON PHARMA INC. operating income (loss) for fiscal 2017 was -$109.98M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$70.63M 10-Q · filed 2021-11-04 | -$134.29M derived: sum of 2 quarters · filed 2021-11-04 | -$197.90M 10-Q · filed 2021-11-04 | -$255.49M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | -$63.66M 10-Q · filed 2021-08-05 | -$127.27M 10-Q · filed 2021-08-05 | -$184.86M derived: sum of 3 quarters · filed 2021-08-05 | -$224.09M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | -$63.60M 10-Q · filed 2021-05-06 | -$121.20M derived: sum of 2 quarters · filed 2021-05-06 | -$160.43M derived: sum of 3 quarters · filed 2021-11-04 | -$179.34M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | -$57.59M 10-K · filed 2021-02-25 | -$96.82M derived: sum of 2 quarters · filed 2021-11-04 | -$115.74M derived: sum of 3 quarters · filed 2021-11-04 | -$167.31M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$39.23M 10-Q · filed 2021-11-04 | -$58.14M derived: sum of 2 quarters · filed 2021-11-04 | -$109.71M 10-Q · filed 2021-11-04 | -$135.29M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$18.91M 10-Q · filed 2021-08-05 | -$70.48M 10-Q · filed 2021-08-05 | -$96.07M derived: sum of 3 quarters · filed 2021-08-05 | -$144.99M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$51.57M 10-Q · filed 2021-05-06 | -$77.15M derived: sum of 2 quarters · filed 2021-05-06 | -$126.08M derived: sum of 3 quarters · filed 2021-05-06 | -$147.21M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$25.58M 10-K · filed 2021-02-25 | -$74.50M derived: sum of 2 quarters · filed 2021-02-25 | -$95.64M derived: sum of 3 quarters · filed 2021-02-25 | -$136.44M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$48.92M 10-K · filed 2021-02-25 | -$70.06M derived: sum of 2 quarters · filed 2021-02-25 | -$110.86M 10-Q · filed 2020-11-05 | -$147.67M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$21.14M 10-K · filed 2021-02-25 | -$61.94M 10-Q · filed 2020-08-06 | -$98.75M derived: sum of 3 quarters · filed 2021-02-25 | -$128.81M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$40.80M 10-K · filed 2021-02-25 | -$77.61M derived: sum of 2 quarters · filed 2021-02-25 | -$107.67M derived: sum of 3 quarters · filed 2021-02-25 | -$137.58M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$36.81M 10-K · filed 2020-02-27 | -$66.87M derived: sum of 2 quarters · filed 2020-02-27 | -$96.77M derived: sum of 3 quarters · filed 2020-02-27 | -$124.41M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$30.06M 10-K · filed 2020-02-27 | -$59.97M derived: sum of 2 quarters · filed 2020-02-27 | -$87.61M 10-Q · filed 2019-11-06 | -$116.24M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$29.91M 10-K · filed 2020-02-27 | -$57.55M 10-Q · filed 2019-08-05 | -$86.18M derived: sum of 3 quarters · filed 2020-02-27 | -$111.76M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$27.64M 10-K · filed 2020-02-27 | -$56.28M derived: sum of 2 quarters · filed 2020-02-27 | -$81.85M derived: sum of 3 quarters · filed 2020-02-27 | -$111.77M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$28.64M 10-K · filed 2019-02-27 | -$54.21M derived: sum of 2 quarters · filed 2019-02-27 | -$84.13M derived: sum of 3 quarters · filed 2019-02-27 | -$109.98M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$25.58M 10-K · filed 2019-02-27 | -$55.49M derived: sum of 2 quarters · filed 2019-02-27 | -$81.35M 10-Q · filed 2018-10-30 | -$103.33M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$29.91M 10-K · filed 2019-02-27 | -$55.77M 10-Q · filed 2018-08-02 | -$77.75M derived: sum of 3 quarters · filed 2019-02-27 | -$98.26M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$25.86M 10-K · filed 2019-02-27 | -$47.84M derived: sum of 2 quarters · filed 2019-02-27 | -$68.35M derived: sum of 3 quarters · filed 2019-02-27 | -$88.01M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$21.99M 10-K · filed 2018-02-27 | -$42.49M derived: sum of 2 quarters · filed 2018-02-27 | -$62.15M derived: sum of 3 quarters · filed 2018-02-27 | -$66.11M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$20.51M 10-K · filed 2018-02-27 | -$40.16M derived: sum of 2 quarters · filed 2018-02-27 | -$44.12M 10-Q · filed 2017-11-07 | -$62.23M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$19.66M 10-K · filed 2018-02-27 | -$23.61M 10-Q · filed 2017-08-03 | -$41.73M derived: sum of 3 quarters · filed 2018-02-27 | -$56.34M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$3.96M 10-K · filed 2018-02-27 | -$22.07M derived: sum of 2 quarters · filed 2018-02-27 | -$36.68M derived: sum of 3 quarters · filed 2018-02-27 | -$49.78M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$18.11M 10-K · filed 2017-03-01 | -$32.73M derived: sum of 2 quarters · filed 2017-03-01 | -$45.82M derived: sum of 3 quarters · filed 2017-03-01 | -$60.88M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$14.61M 10-K · filed 2017-03-01 | -$27.71M derived: sum of 2 quarters · filed 2017-03-01 | -$42.76M 10-Q · filed 2016-11-03 | -$57.32M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$13.09M 10-K · filed 2017-03-01 | -$28.15M 10-Q · filed 2016-08-04 | -$42.71M derived: sum of 3 quarters · filed 2017-03-01 | -$54.10M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$15.06M 10-K · filed 2017-03-01 | -$29.61M derived: sum of 2 quarters · filed 2017-03-01 | -$41.00M derived: sum of 3 quarters · filed 2017-03-01 | -$58.31M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$14.55M 10-K · filed 2016-02-25 | -$25.95M derived: sum of 2 quarters · filed 2016-02-25 | -$43.26M derived: sum of 3 quarters · filed 2016-02-25 | -$55.46M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$11.39M 10-K · filed 2016-02-25 | -$28.70M derived: sum of 2 quarters · filed 2016-02-25 | -$40.91M 10-Q · filed 2015-11-04 | -$44.36M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$17.31M 10-K · filed 2016-02-25 | -$29.52M 10-Q · filed 2015-08-06 | -$32.97M derived: sum of 3 quarters · filed 2016-02-25 | -$39.85M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$12.21M 10-K · filed 2016-02-25 | -$15.66M derived: sum of 2 quarters · filed 2016-02-25 | -$22.54M derived: sum of 3 quarters · filed 2016-02-25 | -$8.39M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$3.45M 10-K · filed 2015-03-02 | -$10.34M derived: sum of 2 quarters · filed 2015-03-02 | $3.82M derived: sum of 3 quarters · filed 2015-03-02 | $6.95M 10-K · filed 2016-02-25 |
| 2013-09-30 | -$6.88M 10-K · filed 2015-03-02 | $7.27M derived: sum of 2 quarters · filed 2015-03-02 | $10.40M 10-Q · filed 2014-11-07 | $2.21M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $14.15M 10-K · filed 2015-03-02 | $17.29M 10-Q · filed 2014-08-12 | $9.09M derived: sum of 3 quarters · filed 2015-03-02 | $2.23M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $3.14M 10-K · filed 2015-03-02 | -$5.06M derived: sum of 2 quarters · filed 2015-03-02 | -$11.92M derived: sum of 3 quarters · filed 2015-03-02 | -$18.82M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$8.19M 10-K · filed 2014-03-17 | -$15.05M derived: sum of 2 quarters · filed 2014-03-17 | -$21.96M derived: sum of 3 quarters · filed 2014-03-17 | -$28.89M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$6.86M 10-K · filed 2014-03-17 | -$13.76M derived: sum of 2 quarters · filed 2014-03-17 | -$20.70M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | -$6.90M 10-K · filed 2014-03-17 | -$13.84M derived: sum of 2 quarters · filed 2014-03-17 | ||
| 2012-03-31 | -$6.93M 10-K · filed 2014-03-17 | |||
| 2011-12-31 | $38.56M 10-K · filed 2014-03-17 |